; and (ii) such other available information and data as the Secretary determines appropriate. (B) Report No later than 1 year after completing the evaluation under subparagraph (A), the Secretary shall issue a report of the evaluation’s findings on the website of the Food and Drug Administration, which shall include the Secretary’s recommendations with respect to continuation and as applicable expansion of the program under this section to encompass— (i) device submissions beyond those identified in subsection (a)(1)(C); and (ii) device changes beyond those described in subsection (a)(2)(A). (2) Sunset This section shall cease to be effective October 1, 2022. (f) Rule of construction Nothing in this section shall be construed to limit the authority of the Secretary to request and review the complete assessment of a certified requestor under this section on a for-cause basis. . (b) Conforming amendments (1) Requirements for premarket approval supplements Section 515(d)(5)(A)(i) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360e(d)(5)(A)(i) ) is amended by inserting , subject to section 524B after that affects safety or effectiveness . (2) Requirements for 30-day notice Section 515(d)(5)(A)(ii) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360e(d)(5)(A)(ii) ) is amended by inserting , subject to section 524B after the date on which the Secretary receives the notice . (3) Requirements for premarket notification; technical correction to reference to section 510(k) Section 510(l) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360(l) ) is amended by striking of this subsection under subsection (m) and inserting of subsection (k) under subsection (m) or section 524B . (4) Misbranded devices Section 502(t) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 352(t) ) is amended by inserting or 524B after section 519 .